4.0
6 May 2015
Former employee
Burlington, MA
Recommend
CEO approval
Business outlook
Pros
Innovative market changing and still leading product. Pervasive view of exceptional quality because of the lives affected by the product. Committed to changing the standard of care in Diabetes
Cons
Danger of being a one trick pony. Product really needs to be a platform. Really long FDA approval cycles limit innovation.